Epidermolysis bullosa refers to a group of genodermatoses that affects the integrity of epithelial layers, phenotypically resulting in severe skin blistering. Dowling-Meara, the major subtype of epidermolysis bullosa simplex, is inherited in an autosomal dominant manner and can be caused by mutations in either the keratin-5 (K5) or the keratin-14 (K14) gene. Currently, no therapeutic approach is known, and the main objective of this study was to identify novel therapeutic targets. We used microarray analysis, semi-quantitative real-time PCR, western blot and ELISA to identify differentially regulated genes in two K14 mutant cell lines carrying the mutations K14 R125P and K14 R125H, respectively. We found kallikrein-related peptidases and matrix metalloproteinases to be upregulated. We also found elevated expression of chemokines, and we observed deregulation of the Cdc42 pathway as well as aberrant expression of cytokeratins and junction proteins. We further demonstrated, that expression of these genes is dependent on interleukin-1 β signaling. To evaluate these data in vivo we analysed the blister fluids of epidermolysis bullosa simplex patients vs. healthy controls and identified matrix metalloproteinase-9 and the chemokine CXCL8/IL-8 as potential therapeutic targets.
References
[1]
Fine JD, Hintner H (2008) Life with Epidermolysis Bullosa. Springer, Vienna.
[2]
Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, et al. (2008) The classification of inherited epidermolysis bullosa (EB): Report of the third international consensus meeting on diagnosis and classification of EB. J Am Acad Dermatol 58: 931–950.
[3]
Moll R, Divo M, Langbein L (2008) The human keratins: biology and pathology. Histochem Cell Biol 129: 705–733.
[4]
Coulombe PA, Kerns ML, Fuchs E (2009) Epidermolysis bullosa simplex: a paradigm for disorders of tissue fragility. J Clin Invest 119: 1784–1793.
[5]
Russell D, Ross H, Lane EB (2010) ERK involvement in resistance to apoptosis in keratinocytes with mutant keratin. J Invest Dermatol 130: 671–681.
[6]
Lu H, Chen J, Planko L, Zigrino P, Klein-Hitpass L, et al. (2007) Induction of inflammatory cytokines by a keratin mutation and their repression by a small molecule in a mouse model for EBS. J Invest Dermatol 127: 2781–2789.
[7]
Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M (2001) Keratins and the keratinocyte activation cycle. J Invest Dermatol 116: 633–640.
[8]
Morley SM, D`Alessandro M, Sexton C, Rugg EL, Navsaria H, et al. (2003) Generation and characterization of epidermolysis bullosa simplex cell lines: scratch assays show faster migration with disruptive keratin mutations. Br J Dermatol 149: 46–58.
[9]
Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, et al. (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nature Genetics 29: 365–371.
[10]
Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44–57.
[11]
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2？ΔΔCT method. Methods 25: 402–408.
[12]
Wally V, Lettner T, Peckl-Schmid D, Klausegger A, Hainzl S, et al.. (2013) The pathogenic role of interleukin-1 beta in severe epidermolysis bullosa simplex. J Invest Dermatol [in press].
[13]
Caubet C, Jonca N, Brattsand M, Guerrin M, Bernard D, et al. (2004) Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 122: 1235–1244.
[14]
Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function and biochemistry. Circ Res 92: 827–839.
Takai Y, Sasaki T, Matozaki T (2001) Small GTP-binding proteins. Physiol Rev 81: 153–208.
[17]
Leung T, Chen XQ, Tan I, Manser E, Lim L (1998) Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a Cdc42 effector in promoting cytoskeletal reorganization. Mol Cell Biol 18: 130–140.
[18]
Nakamura N, Oshiro N, Fukata Y, Amano M, Fukata M, et al. (2000) Phosphorylation of ERM proteins at filopodia induced by Cdc42. Genes Cells 5: 571–581.
[19]
Wagner M, Hintner H, Bauer JW, Onder K (2012) Gene expression analysis of an epidermolysis bullosa simplex Dowling-Meara cell line by subtractive hybridization: recapitulation of cellular differentiation, migration and wound healing. Exp Dermatol 21: 111–117.
[20]
Retief CR, Malkinson FD, Pearson RW (1999) Two familial cases of epidermolysis bullosa simplex successfully treated with tetracycline. Arch Dermatol 135: 997–998.
[21]
Veien NK, Buus SK (2000) Treatment of epidermolysis bullosa simplex (EBS) with tetracycline. Arch Dermatol 136: 424–425.
[22]
Griffin MO, Fricovsky E, Ceballos G, Villarreal F (2010) Tetracyclines: a pleiotropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol 299: 539–548.
[23]
Cirillo N, Lanza M, Rossiello L, Gombos F, Lanza A (2007) Defining the involvement of proteinases in pemphigus vulgaris: Evidence of matrix metalloproteinase-9 overexpression in experimental models of disease. J Cell Physiol 212: 36–41.
[24]
Liu Z, Giudice GJ, Zhou X, Swartz SJ, Troy JL, et al. (1997) A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest 100: 1256–1263.
[25]
Schmidt E, Reimer S, Kruse N, Broeckner EB, Zillikens D (2001) The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone. Clin Exp Immunol 124: 157–162.
[26]
Tsuruta D, Sowa J, Tateishi C, Obase Y, Tsubura A, et al. (2011) Atypical epidermolysis bullosa simplex with a missense keratin 14 mutation p.Arg125Cys. J Dermatol 38: 1177–1179.
[27]
Darwich E, Vicente A, Bolling MC, Gonzalez-Ensenat MA, Cusi V, et al. (2011) Extensive acantholysis as the major histological feature of a severe case of Dowling-Meara-epidermolysis bullosa simplex: a reappraisal of acantholysis in the newborn. Eur J Dermatol 21: 966–971.
[28]
Lloyd C, Yu QC, Cheng JA, Turksen K, Degenstein L, et al. (1995) The basal keratin network of stratified squamous epithelia – defining K15 function in the absence of K14. J Cell Biol 129: 1329–1344.
[29]
Wally V, Brunner M, Lettner T, Wagner M, Koller U, et al. (2010) K14 mRNA reprogramming for dominant epidermolysis bullosa simplex. Hum Mol Genet 19: 4715–4725.
[30]
Cabral RM, Tattersall D, Patel V, McPhail GD, Hatzimasoura E, et al. (2012) The DSPII splice variant is critical for desmosome-mediated HaCaT keratinocyte adhesion. J Cell Sci 15: 2853–2861.
[31]
Wan H, Dopping-Hepenstal PJC, Gratian MJ, Stone MG, Zhu G, et al. (2004) Striate palmoplantar keratoderma arising from desmoplakin and desmoglein 1 mutations is associated with contrasting perturbations of desmosomes and the keratin filament network. Br J Dermatol 150: 878–891.
[32]
Russell D, Andrews PD, James J, Lane EB (2004) Mechanical stress induces profound remodelling of keratin filaments and cell junctions in epidermolysis bullosa simplex keratinocytes. J Cell Sci 117: 5233–5243.
[33]
Liovic M, D`Alessandro M, Tomic-Canic M, Bolshakov VN, Coats SE, et al. (2009) Severe keratin 5 and 14 mutations induce down-regulation of junction proteins in keratinocytes. Exp Cell Res 315: 2995–3003.
[34]
Puls A, Eliopoulos AG, Nobes CD, Bridges T, Young LS, et al. (1999) Activation of the small GTPase Cdc42 by the inflammatory cytokines TNFα and IL-1, and by the Epstein-Barr virus transforming protein LMP1. J Cell Sci 112: 2983–2992.
[35]
Bagrodia S, Dèrijard B, Davis RJ, Cerione RA (1995) Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 Mitogen-activated protein kinase activation. J Biol Chem 270: 27995–27998.
[36]
Prag S, Parson M, Keppler MD, Ameer-Beg SM, Barber P, et al. (2007) Activated ezrin promotes cell migration through recruitment of the GEF Dbl to lipid rafts and preferential downstream activation of Cdc42. Mol Biol Cell 18: 2935–2948.
[37]
Davis W, Stephens LR, Hawkins PT, Saklatvala J (1999) Synergistic activation of JNK/SAPK by interleukin-1 and platelet-derived growth factor is independent of Rac and Cdc42. Biochem J 338: 387–392.
[38]
Lai Y, Shen Y, Liu XH, Zhang Y, Zeng Y, et al. (2011) Interleukin-8 induces the endothelial cell migration through the activation of phosphoinositide 3-kinase-Rac1/RhoA pathway. Int J Biol Sci 7: 782–791.
[39]
Ijima Y, Koabyashi M, Kubota E (2001) Role of interleukin-1 in induction of matrix metalloproteinases synthesized by rat temporomandibular joint chondrocytes and disc cells. Eur J Oral Sci 109: 50–59.
[40]
Turchi L, Chassot A-A, Bourget I, Baldescchi C, Ortonne JP, et al. (2003) Cross-talk between RhoGTPases and stress activated kinases for matrix metalloproteinase-9 induction in response to keratinocyte injury. J Invest Dermatol 121: 1291–1300.
[41]
Kedrin D, van Rheenen J, Hernandez L, Condeelis J, Segall JE (2007) Cell motility and cytoskeletal regulation in invasion and metastasis. J Mammary Gland Biol Neoplasia 12: 143–152.
[42]
Kurisu S, Takenawa T (2009) The WASP and WAVE family proteins. Genome Biol 10: 226.
[43]
Mullins RD (2000) How WASP-family proteins and the Arp2/3 complex convert intracellular signals into cytoskeletal structures. Curr Opin Cell Biol 12: 91–96.
